 |
FDA Approval Activities for this Drug
Namenda (Memantine Hydrochloride) Tablets, Forest NDA 21-487 | Namenda tablets, Forest Laboratories, Control Supplement | Namenda Oral Solution, Forest Labs, Approval | Namenda (memantine HCl) Tablets, Forest Labs, Labeling Revision | Namenda (memantine hydrochloride) Tablets, Forest Labs, Formulation Revision | Namenda (memantine hydrochloride) Tablets, Forest Labs, Labeling Revision | Namenda (memantine hydrochloride) Oral Solution, Forest Labs, Labeling Revision | Namenda (memantine hydrochloride) Tablets, Forest Labs, Labeling Revision | Namenda (memantine hydrochloride) Oral Solution, Forest Labs, Labeling Revision | Memantine Hydrochloride Tablets, Orchid Healthcare, Tentative Approval | Memantine Hydrochloride Tablets, Amneal Pharmaceuticals, Tentative Approval | Memantine Hydrochloride Tablets, Lupin Ltd., Tentative Approval | Memantine Hydrochloride Tablets, Teva Pharmaceuticals, Tentative Approval | Memantine Hydrochloride Tablets, Mylan Pharmaceuticals Inc., Tentative Approval | Memantine Hydrochloride Tablets, Reddy’s Laboratories Limited, Approval | Memantine Hydrochloride Tablets, Sun Pharma Global, Tentative Approval | Memantine Hydrochloride Tablets, Upsher-Smith Laboratories, Inc., Tentative Approval | Namenda XR (memantine hydrochloride) Extended Release Capsules, Forest Laboratories, Inc., Approval | Memantine Hydrochloride Tablets, Torrent Pharmaceuticals, Ltd., Tentative Approval | Memantine Hydrochloride Tablets, Teva Pharmaceuticals, Approval
View updates.
|